"A Stable Aqueous Aldehyde Solution"

The Martin Family Trust
Granted App No 7125/DELNP/2009 Patent 282917 Chemical

Patent information

IP India · live record
Application number
7125/DELNP/2009
Filing date
04 November 2009
Status
Granted
Legal status
Ceased
Publication number
26/2010
Publication type
INA
Invention field
Chemical
Patent number
282917
Grant date
28 April 2017
Next renewal due
04 April 2025Overdue

Abstract

The invention provides a method of manufacturing a stable aldehyde-surfactant complex solution wherein at least one aldehyde is added to a surfactant in a first aliquot of water, at a temperature of between 40°C to 50°C, the aldehyde is allowed to interact with the surfactant or detergent, in a complexing reaction, for at least 15 minutes whilst maintaining the temperature between 40°C to 50°C to produce an aldehyde-surfactant complex solution, and a second aliquot of water is added after at least 15 minutes to cool the aldehyde-surfactant complex solution to below 40°C to stop the complexing reaction.

Applicants

1
South Africa
THE MARTIN FAMILY TRUST 2 SITA AVENUE, WILRO PARK, 1724 ROODEPOORT, REPUBLIC OF SOUTH AFRICA.

Inventors

2
South Africa
MARTIN, ANTONIETTA PAMELA2 SITA AVENUE, WILRO PARK, 1724 ROODEPOORT, REPUBLIC OF SOUTH AFRICA.
Ireland
SKELLY, MARY G.34 TUBBERMORE ROAD, APARTMENT #3, DALKEY, DUBLIN, IRELAND.

Claims

21
1 A stable aqueous aldehyde solution that includes: (a) an aldehyde comprising at least one of the following: a monoaldehyde (Diagram 1), a dialdehyde (Diagram 2) and a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R-CHO OHC-R1-CHO R3-CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen, a straight hydrocarbon chain between 1 and 12 carbon atoms in length, or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 12 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms. (b) a surfactant or detergent chosen from any one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD); (c) a sufficient amount of a pH modifier to bring the pH of the solution to within a 6.0 to 8.5 range; and (d) a buffer comprising at least one of the following: calcium acetate, magnesium acetate, sodium acetate, sodium acetate tri-hydrate, potassium acetate, lithium acetate, propylene glycol, hexalene glycol, sodium phosphate, sodium tri-phosphate, potassium phosphate, lithium phosphate, zinc perchlorate, zinc sulphate, cupric chlorate and cupric sulphate.
2 A stable aqueous aldehyde solution according to claim 1 wherein the aldehyde comprises at least one of the following: formaldehyde, acetaldehyde, proprionaldehyde, butraldehyde, pentanaldehyde, hexanaldehyde, heptanaldehyde, octanaldehyde, nonanaldehyde, succinaldehyde, Glyoxal™, 2-ethyl hexanaldehyde, iso-valeraldehyde, chloraldehyde hydrate, furfuraldehyde, paraformaldehyde.
3 A stable aqueous aldehyde solution according to claim 1 wherein the aldehyde is selected from one of the following: glutaraldehyde and Glyoxal™ (ethane dialdehyde); Glyoxal™ chloraldehyde trihydrate; acetaldehyde and Glyoxal™; paraformaldehyde and glutaraldehyde, glutaraldehyde and succinaldehyde and Glyoxal™ and succinaldehyde.
4 A stable aqueous aqueous aldehyde solution according to any one of claims 1 or 3 which includes the surfactant or detergent in a 0.1% to 25% m/v concentration.
5 A stable aqueous aldehyde solution according to claim 4 wherein the surfactant is a non-ionic surfactant.
6 A stable aqueous aldehyde solution according to claim 5 wherein the surfactant is an alcohol ethoxylate surfactant.
7 A stable aqueous aldehyde solution according to claim 5 or 6 wherein the alcohol ethoxylate surfactant includes 3 to 9 ethoxylate groups.
8 A stable aqueous aldehyde solution according to any one of claims 1 to 7 wherein the buffer is a mixture of sodium acetate trihydrate and potassium acetate.
9 A stable aqueous aldehyde solution according to claim 8 which includes the buffer in at least a 0,05% m/v concentration.
10 A stable aqueous aldehyde solution according to any one of claims 1 to 9 wherein the pH modifier comprises at least one of the following: potassium hydroxide, sodium hydroxide, sodium phosphate and sodium bicarbonate.
11 A stable aqueous aldehyde solution according to claim 10 wherein the pH modifier is potassium hydroxide in a one molar solution.
12 A stable aqueous aldehyde solution according to any one of claims 1 to 11 which includes a twin chain quaternary ammonium compound with sterically hindered ammonium groups.
13 A stable aqueous aldehyde solution according to any one of claims 1 to 121 which includes one or more of the following trace elements: calcium, magnesium, zinc, copper, titanium, iron, silver, sodium and gold.
14 A stable aqueous aldehyde solution according to claim 13 wherein copper is included as cupric chlorate or cupric sulphate.
15 A stable aqueous aldehyde solution according to claim 14 wherein zinc is included as zinc perchlorate, zinc chloride or zinc sulphate.
16 A stable aqueous aldehyde solution according to any one of claims 1 to 15 which includes sodium nitrite in a concentration not exceeding 0,005% m/v.
17 A biocidal dispersant which includes the stable aqueous aldehyde solution according to any one of claims 1 to 16, diluted with distilled water.
18 A biocidal dispersant according to claim 17 which includes the aldehyde in a 0,001% to 8% m/v concentration.
19 A method of manufacturing a stable aldehyde surfactant complex solution wherein at least one aldehyde is added to a surfactant in a first aliquot of water, at a temperature of between 40°C to 50°C, the aldehyde is allowed to interact with the surfactant for at least 15 minutes whilst maintaining the temperature between 40°C to 50°C to produce an aldehyde-surfactant complex solution, and wherein a second aliquot of water is added after at least 15 minutes to cool the aldehyde-surfactant complex solution to below 40°C.
20 A method of manufacturing a stable aqueous aldehyde solution wherein the aldehyde comprises at least one of the following: a monoaldehyde (Diagram 1), a dialdehyde (Diagram 2) and a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R-CHO OHC-R-CHO R3-CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen or a straight hydrocarbon chain between 1 and 10 carbon atoms in length or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 10 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms.
21 A method of manufacturing a stable aqueous aldehyde solution according to claim 20 wherein the surfactant is at least one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD). !2. A method of manufacturing a stable aqueous aldehyde solution according to claim 20 or 21 wherein the pH is maintained, during manufacture, within a 7.0 to 8.5 range.

Specification

Show full textCollapse

BACKGROUND OF THE INVENTION

[0001] This invention relates generally to a stable aqueous aldehyde solution or mixtures of aldehyde solutions.

[0002] Aldehydes are widely used in many industrial processes. Importantly, due to the ability of an aldehyde functional group of an aldehyde molecule to react with free amine groups of, for example, a cell membrane of a microorganism, the aldehyde demonstrates a biocidal effect by disrupting and ultimately killing the microorganism.

[0003] Aldehydes are commonly used as preservatives, sanitizers, disinfectants and sporocidal agents.

[0004] However aldehydes (with the exception of formaldehyde and aldehydes with carbon chain lengths of 2 to 4 carbon atoms) have a tendency, especially at low concentrations, to adopt a cyclic molecular configuration which results in the aldehyde molecule losing its biocidal efficacy. Furthermore, aldehydes (including formaldehyde and aldehydes with carbon chain lengths of 2 to 4 carbon atoms) when in a monomeric form, which is prevalent at low concentrations, have a tendency to diffuse into the atmosphere causing a health hazard as potent dermal and respiratory irritants.

[0005] Aldehydes at relatively higher concentrations, left over a period of time, will polymerize with other aldehyde molecules, a process which accelerates at temperatures greater than 50°C (and at less than 4°C for aldehydes that have chain lengths of less than 5 carbon atoms). Once again this will result in a loss of the biocidal effect.

[0006] It is known in the art to take a product containing an aldehyde solution and, before use, to dilute it. In doing so the tendency of the aldehyde molecule to polymerize is reduced. Raising the pH subsequently activates the aldehyde solution. The activation increases the reactivity of the aldehyde functional groups with the amine groups and the associated biocidal effect upon cell membranes. However the stability of the aldehyde solution is compromised in so doing to the extent that the solution is only stable for several days.

[0007] There are a number of problems associated with the use of an aldehyde solution as a biocidal product. Not only does a user have to dilute the product prior to use but also activate it. The resultant diluted and activated product is corrosive, due to the high pH, and unstable beyond a month.

[0008] The invention at least partially addresses the aforementioned problems. SUMMARY OF INVENTION

[0009] The invention provides a stable aqueous aldehyde solution that includes: (a) an aldehyde comprising at least one of the following: a monoaldehyde (Diagram 1), a cyclic aldehyde (Diagram 2) and a dialdehyde (Diagram2) and a monoaldehyde or a cyclic aldehyde in a 0.001% to 25% m/v concentration: R-CHO OHC-R1-CHO R3-CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen, a straight hydrocarbon chain between 1 and 12 carbon atoms in length, or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 12 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms. (b) a surfactant or detergent chosen from any one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD); (c) a sufficient amount of a pH modifier to bring the pH of the solution to within a 6.0 to 8.5 range; and (d) a buffer comprising at least one of the following: calcium acetate, magnesium acetate, sodium acetate, sodium acetate tri-hydrate, potassium acetate, lithium acetate, propylene glycol, hexalene glycol, sodium phosphate, sodium tri-phosphate, potassium phosphate, lithium phosphate, zinc perchlorate, zinc sulphate, cupric chlorate and cupric sulphate.

[0010] "Stable", in the context of the invention, refers to an aqueous aldehyde solution capable of being stored for a period of at least six months without the aldehyde molecules polymerizing or the pH dropping below 5.

[0011] The stable aqueous aldehyde solution may include any of the following aldehydes: formaldehyde, acetaldehyde, proprionaldehyde, butraldehyde, pentanaldehyde, hexanaldehyde, heptanaldehyde, octanaldehyde, nonanaldehyde, glutaraldehyde, succinaldehyde, Glyoxal™, 2-ethyl hexanal, iso-valeraldehyde, chloraldehyde hydrate, furfuraldehyde, paraformaldehyde.

[0012] Preferably, the stable aqueous aldehyde solution includes any of the following aldehyde mixtures: glutaraldehyde and Glyoxal™ (ethane dialdehyde); Glyoxal™ chloradehyde trihydrate; acetaldehyde and Glyoxal™; paraformaldehyde and glutaraldehyde, glutaraldehyde and succinaldehyde and Glyoxal™ and succinaldehyde.

[0013] The stable aqueous aldehyde solution preferably includes the surfactant or detergent in a 0.1% to 25% m/v concentration.

[0014] The surfactant is preferably a non-ionic surfactant such as an alcohol ethoxylate surfactant.

[0015] The alcohol ethoxylate surfactant may include 3 to 9 ethoxylate groups depending on the composition of the stable aqueous aldehyde solution and the foaming properties required for a specific application of the stable aqueous aldehyde solution.

[0016] The buffer is preferably a mixture of sodium acetate trihydrate and potassium acetate.

[0017] To maintain the pH of the stable aqueous aldehyde solution at least at 5 or above for at least 6 months, the buffer is preferably included in the solution in a concentration of at least 0.05% m/v.

[0018] The pH modifier may be any one or more of the following compounds: potassium hydroxide, sodium hydroxide, sodium phosphate and sodium bicarbonate.

[0019] The pH modifier is preferably potassium hydroxide in a one molar solution.

[0020] The pH of the stable aqueous aldehyde solution may be maintained, at the time of manufacture, within a 7.0 to 8.5 range.

[0021] A twin chain quaternary ammonium compound with sterically hindered armonium groups may be added to the stable aqueous aldehyde solution for its fungicidal and foaming properties.

[0022] To enhance the biocidal efficacy of the stable aqueous aldehyde solution one or more of the following trace elements may be added to the solution: calcium, magnesium, zinc, copper, titanium, iron, silver, sodium and gold.

[0023] Sodium nitrite may be added to the stable aqueous aldehyde solution in a concentration exceeding 0,005% m/v for its anti-corrosive properties.

[0024] Copper may be added to the stable aqueous aldehyde solution e.g. as cupric chlorate or cupric sulphate.

[0025] Zinc may be added to the stable aqueous aldehyde solution e.g. as zinc perchlorate, zinc chloride or zinc sulphate.

[0026] The stable aqueous aldehyde solution may be diluted either with distilled or potable water, an alcohol or a solvent to produce a biocidal dispersant with a greater biocidal efficacy at lower temperatures than the stable aqueous aldehyde solution in an undiluted state.

[0027] The invention also provides a method of manufacturing a stable aldehyde-surfactant complex solution wherein at least one aldehyde is added to a surfactant in a first aliquot of water, at a temperature of between 40°C to 50°C, the aldehyde is allowed to interact with the surfactant or detergent, in a complexing reaction, for at least 15 minutes whilst maintaining the temperature between 40°C to 50°C to produce an aldehyde-surfactant complex solution, and a second aliquot of water is added after at least 15 minutes to cool the aldehyde-surfactant complex solution to below 40°C to stop the complexing reaction.

[0028] The aldehyde may be a monoaldehyde (Diagram 1), dialdehyde (Diagram 2) or a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R-CHO OHC-R-CHO R3 - CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen or a straight hydrocarbon chain between 1 and 10 carbon atoms in length or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 10 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms.

[0029] The surfactant may be at least one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD). BRIEF DESCRIPTION OF THE DRAWINGS

[0030] The invention is further described by way of example with reference to the accompanying drawings in which: Figure 1 illustrates a commercially available mass spectroscopy scan of acetaldehyde; Figure 2A illustrates a mass spectroscopy scan of acetaldehyde treated in accordance with the invention; Figure 2B illustrates an expanded portion of the mass spectroscopy scan of Figure 2A; Figure 3A illustrates a mass spectroscopy scan of untreated acetaldehyde and a surfactant; and Figure 3B illustrates an expanded portion of the mass spectroscopy scan of Figure 3A. DESCRIPTION OF PREFERRED EMBODIMENT

[0031] A stable aqueous aldehyde solution, according to the invention, is manufactured, in a concentrate solution (i.e. comprising aldehyde compounds in the range 2 to 10% m/v), by first adding a non-ionic surfactant i.e. alcohol ethoxylate (with 3, 7 or 9 ethoxylate groups), to water heated to a temperature between 40° and 50°C followed by an aldehyde or an aldehyde mixture chosen from Table 1 (hereinafter referred to as "the aldehyde"). Table 1:

(Table Removed)

[0032] The aldehyde is allowed to complex with the preferred alcohol ethoxylate (as indicated in Table 1 alongside the relevant aldehyde) for a period of between 15 and 30 minutes. This produces an aldehyde-surfactant solution, whilst maintaining the temperature of the body of water between 30°C and 70°C. During this period of heating the aldehyde complexes with the alcohol ethoxylate substantially to completion (see Figures 2 and 3).

[0033] Following this period, a further amount of water, at a temperature of less than 25°C, is added to the aldehyde-surfactant complex solution to reduce the temperature of the solution to below 30°C thereby to stop the complexing reaction of the alcohol ethoxylate with the aldehyde.

[0034] A pH modifier, such as potassium hydroxide, is then added in a sufficient quantity to adjust the pH of the succinaldehyde-surfactant complex solution to within 7.0 to 8.5 Potassium hydroxide is used in a one molar solution.

[0035] Finally a buffer mixture comprising sodium acetate trihydrate and potassium acetate is added to the aldehyde-surfactant complex solution to produce a stable aqueous aldehyde solution in the concentrate solution.

[0036] Sodium acetate trihydrate and potassium acetate each have a concentration in the buffer mixture of between 0.250 to 0.500 grams/liter. This concentrated solution is diluted when added to the aldehyde-surfactant complex solution to within the range 0.005% to 0,1% m/v.

[0037] The buffer mixture maintains the pH of the concentrate during the shelf life of the stable aqueous aldehyde solution, i.e. at least 6 months from manufacture, at least above pH5.

[0038] The concentrate solution of the stable aqueous aldehyde solution includes the following contents in the following concentrations: (a) aldehyde- 0.01% to 25% m/v; (b) alcohol ethoxylate - 0.1 % to 25 %m/v; and (c) the buffer mixture - 0.05% to 0,1% m/v.

[0039] To enhance the biocidal efficacy of the stable aqueous aldehyde solution, one or more of the following trace elements are added, in a concentration not exceeding 5ppm, to the solution: calcium, magnesium, zinc, copper, titanium, iron, silver and gold.

[0040] To produce a biocidal product capable of application, by a variety of means, to a variety of surfaces, the concentrate solution of the stable aqueous aldehyde solution is diluted with potable water to produce a dispersant with aldehyde in a 0.001% to 8% m/v concentration.

[0041] The dispersant finds application as an additive to degreasing agents, detergents, thickeners, fragrances, colorants, skin conditioners and a variety of anti-microbial products. This list is exemplary and is by no means exhaustive.

[0042] On the other hand, the concentrate solution with aldehyde in a concentration in excess of 10% m/v is a favoured composition in which to transport the stable aqueous aldehyde solution.

[0043] An end user, on receipt of the concentrate solution, merely has to dilute the concentrate solution by a required dilution ratio for ready incorporation with other appropriate additives, to produce products such as anti-microbial hand soap, hand sanitizers, medical equipment disinfectants, dishwashing liquids, and laundry detergents. Once again, this list is exemplary and is by no means exhaustive.

[0044] The concentrate solution finds further application, incorporated with other mediums such as paints, resins etc, to provide a sustained release of the biocidal efficacy.

[0045] It is believed that the dispersant and the concentrate solution, in the variety of applications exemplified above, have lower volatility, lower toxicity and corrosive properties, greater stability and biocidal efficacy at room temperatures relatively to an aldehyde (e.g. acetaldehyde and/or Glyoxal™) that has not been subjected to the method of the invention (i.e. at least not bound to a surfactant in a complex configuration), and which is used in comparative applications (see Table 2, Table 3 and Table 4).

[0046] The stable aqueous aldehyde solution, like an uncomplexed aldehyde, is incompatible with certain unhindered nitrogen containing chemicals such as triethalamines and cocoamides. This incompatability needs to be kept in consideration when formulating with any aldehyde biocide.

[0047] Example 1: Proof of Complexing:

[0048] To demonstrate complexing of the aldehyde with the surfactant a comparison is made between Figure 1 and Figure 2.

[0049] From Figure 2 it is evident that there are no free acetaldehyde spectra between 0 to 100 mass to charge (m/z) where acetaldehyde indicative peaks would appear (see Figure 1) if "free" aldehyde was present.

[0050] Figure 3 exhibits the separate mass spectra of the surfactant and the aldehyde used in Figure 2, but uncomplexed with each other. By comparing Figure 2 with Figure 3 it can be seen that the spectra of Figure 2 have shifted to the right with respect to the spectra of Figure 3, indicating the complexing of the aldehyde with the surfactant.

[0051] The sample of Figure 2 was produced by adding 50ml acetaldehyde (10% m/v) to 450ml of a "premix" solution (2.5I bacterial filtered water, 0,9% m/v alcohol ethoxylate 7, 13,7g potassium acetate, 13,7g sodium acetate trihydrate) and heated to 30°C for 15 minutes.

[0052] The sample of Figure 3 was a sample of acetaldehyde (99% m/v), mixed with an alcohol ethoxylate 7 surfactant without being subjected to the method of the invention.

[0053] The method, materials and equipment used in this example are as follows: Agilent 1299LC; Agilent 6210 Agilent 6210 time-of-flight (TOF) mass spectroscopy; LC: mobile phase: 50:50 H20:MeCN + 0.1% formic acid; flow: 0.2 ml/min; injection volume: 10 microliter; samples were directly infused into the TOF; TOF: positive ionization; gas Temp 300°C; drying gas 8L7min; nebulizer 35 psig; Vcap 3500V; fragmenter 140V; skimmer 60V; ref masses: 118.086255 and 922.009798.

[0054] The TOF system is used in combination with a dual-nebulizer ESI source and an automated calibrant delivery system to continuously introduce low-level reference masses to achieve accurate mass assignment. For the analysis, the drying gas flow was set at 8L/min, with gas temperature at 300°C. The nebulizer was set to 35 psig and capillary voltage was 3500V. A Fragmenter setting of 140V was used with skimmer 60V. The mass range was set to 100-3500 m/z with transients/scan equal to 10000. Internal reference mass correction was used.

[0055] Stability tests, as above, were repeated on samples of the aldehydes (1 to 21) indicated in the table below. The results showed the same complexing phenomena.

[0056] Example 2: Biocidal efficacy tests:

[0057] Tests were conducted using a South African Bureau of Standards (SABS) method (i.e. SABS1593), a Kelsey Sykes modified suspension test. The microorganism used in the test was Bacillus subtilis var globi. The results of the tests are tabulated below: Table 2:

(Table Removed)

[0058] The same aldehydes as used above (i.e. 1 to 21) were re-subjected to the test, with the relevant surfactant added, but without pH adjustment and without the addition of a pH modifier and a buffer. All the aldehydes failed the 8 hour contact time with the exception of glutaraldehyde (sample 13) with a "borderline" pass.

[0059] As evident from the above the invention appears effective at improving the biocidal efficacy of aldehydes.

[0060] Example 3: Stability tests. Table 3

(Table Removed)

[0061] The tests conducted at 40°C are accelerated stability tests i.e. a 2 week period at the elected temperature (40°C) is equivalent to a 6 month "shelf-life" period at 25°C.

[0062] The aldehyde samples chosen for this test are merely exemplary of the vast number of possible aldehyde and mixed aldehyde permutations of the invention.

[0063] The three month results were not available at the time of filing.

[0064] Example 4: Virucidal efficacy tests.

[0065] The same aldehyde samples as used in Example 3 (i.e. 1 to 25) were tested for virucidal efficacy using a standard SABS method (SANS1288) which uses a bacteriophage with virus standard to represent enveloped and non-enveloped viruses Each of the samples passed the test.

WE CLAIM: 1. A stable aqueous aldehyde solution that includes: (a) an aldehyde comprising at least one of the following: a monoaldehyde (Diagram 1), a dialdehyde (Diagram 2) and a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R-CHO OHC-R1-CHO R3-CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen, a straight hydrocarbon chain between 1 and 12 carbon atoms in length, or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 12 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms. (b) a surfactant or detergent chosen from any one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD); (c) a sufficient amount of a pH modifier to bring the pH of the solution to within a 6.0 to 8.5 range; and (d) a buffer comprising at least one of the following: calcium acetate, magnesium acetate, sodium acetate, sodium acetate tri-hydrate, potassium acetate, lithium acetate, propylene glycol, hexalene glycol, sodium phosphate, sodium tri-phosphate, potassium phosphate, lithium phosphate, zinc perchlorate, zinc sulphate, cupric chlorate and cupric sulphate. 2. A stable aqueous aldehyde solution according to claim 1 wherein the aldehyde comprises at least one of the following: formaldehyde, acetaldehyde, proprionaldehyde, butraldehyde, pentanaldehyde, hexanaldehyde, heptanaldehyde, octanaldehyde, nonanaldehyde, succinaldehyde, Glyoxal™, 2-ethyl hexanaldehyde, iso-valeraldehyde, chloraldehyde hydrate, furfuraldehyde, paraformaldehyde. 3. A stable aqueous aldehyde solution according to claim 1 wherein the aldehyde is selected from one of the following: glutaraldehyde and Glyoxal™ (ethane dialdehyde); Glyoxal™ chloraldehyde trihydrate; acetaldehyde and Glyoxal™; paraformaldehyde and glutaraldehyde, glutaraldehyde and succinaldehyde and Glyoxal™ and succinaldehyde. 4. A stable aqueous aqueous aldehyde solution according to any one of claims 1 or 3 which includes the surfactant or detergent in a 0.1% to 25% m/v concentration. 5. A stable aqueous aldehyde solution according to claim 4 wherein the surfactant is a non-ionic surfactant. 6. A stable aqueous aldehyde solution according to claim 5 wherein the surfactant is an alcohol ethoxylate surfactant. 7. A stable aqueous aldehyde solution according to claim 5 or 6 wherein the alcohol ethoxylate surfactant includes 3 to 9 ethoxylate groups. 8. A stable aqueous aldehyde solution according to any one of claims 1 to 7 wherein the buffer is a mixture of sodium acetate trihydrate and potassium acetate. 9. A stable aqueous aldehyde solution according to claim 8 which includes the buffer in at least a 0,05% m/v concentration. 10. A stable aqueous aldehyde solution according to any one of claims 1 to 9 wherein the pH modifier comprises at least one of the following: potassium hydroxide, sodium hydroxide, sodium phosphate and sodium bicarbonate. 11. A stable aqueous aldehyde solution according to claim 10 wherein the pH modifier is potassium hydroxide in a one molar solution. 12. A stable aqueous aldehyde solution according to any one of claims 1 to 11 which includes a twin chain quaternary ammonium compound with sterically hindered ammonium groups. 13. A stable aqueous aldehyde solution according to any one of claims 1 to 121 which includes one or more of the following trace elements: calcium, magnesium, zinc, copper, titanium, iron, silver, sodium and gold. 14. A stable aqueous aldehyde solution according to claim 13 wherein copper is included as cupric chlorate or cupric sulphate. 15. A stable aqueous aldehyde solution according to claim 14 wherein zinc is included as zinc perchlorate, zinc chloride or zinc sulphate. 16. A stable aqueous aldehyde solution according to any one of claims 1 to 15 which includes sodium nitrite in a concentration not exceeding 0,005% m/v. 17. A biocidal dispersant which includes the stable aqueous aldehyde solution according to any one of claims 1 to 16, diluted with distilled water. 18. A biocidal dispersant according to claim 17 which includes the aldehyde in a 0,001% to 8% m/v concentration. 19. A method of manufacturing a stable aldehyde surfactant complex solution wherein at least one aldehyde is added to a surfactant in a first aliquot of water, at a temperature of between 40°C to 50°C, the aldehyde is allowed to interact with the surfactant for at least 15 minutes whilst maintaining the temperature between 40°C to 50°C to produce an aldehyde-surfactant complex solution, and wherein a second aliquot of water is added after at least 15 minutes to cool the aldehyde-surfactant complex solution to below 40°C. 20. A method of manufacturing a stable aqueous aldehyde solution wherein the aldehyde comprises at least one of the following: a monoaldehyde (Diagram 1), a dialdehyde (Diagram 2) and a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R-CHO OHC-R-CHO R3-CHO Diagram 1 Diagram 2 Diagram 3 and wherein: R = hydrogen or a straight hydrocarbon chain between 1 and 10 carbon atoms in length or a branded hydrocarbon chain between 2 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 10 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms. 21. A method of manufacturing a stable aqueous aldehyde solution according to claim 20 wherein the surfactant is at least one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sulphonic acid, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD). !2. A method of manufacturing a stable aqueous aldehyde solution according to claim 20 or 21 wherein the pH is maintained, during manufacture, within a 7.0 to 8.5 range.

Documents

Sign in to open
Application documents
1 7125-DELNP-2009-GPA (15-01-2010).pdf 15 Jan 2010
2 7125-DELNP-2009-Correspondence-Others (15-01-2010).pdf 15 Jan 2010
3 7125-DELNP-2009-Form-18-(23-02-2011).pdf 23 Feb 2011
4 7125-DELNP-2009-Correspondence-Others-(23-02-2011).pdf 23 Feb 2011
5 7125-delnp-2009-form-5.pdf 21 Aug 2011
6 7125-delnp-2009-form-3.pdf 21 Aug 2011
7 7125-delnp-2009-form-2.pdf 21 Aug 2011
8 7125-delnp-2009-form-1.pdf 21 Aug 2011
9 7125-delnp-2009-drawings.pdf 21 Aug 2011
10 7125-delnp-2009-description (complete).pdf 21 Aug 2011
11 7125-delnp-2009-correspondence-others.pdf 21 Aug 2011
12 7125-delnp-2009-claims.pdf 21 Aug 2011
13 7125-delnp-2009-abstract.pdf 21 Aug 2011
14 7125-delnp-2009-GPA-(11-07-2012).pdf 11 Jul 2012
15 7125-delnp-2009-Form-2-(11-07-2012).pdf 11 Jul 2012
16 7125-delnp-2009-Form-1-(11-07-2012).pdf 11 Jul 2012
17 7125-delnp-2009-Correspondence Others-(11-07-2012).pdf 11 Jul 2012
18 7125-delnp-2009-Assignment-(11-07-2012).pdf 11 Jul 2012
19 7125-delnp-2009-Petition-137-(09-12-2015).pdf 09 Dec 2015
20 7125-delnp-2009-Others-(09-12-2015).pdf 09 Dec 2015
21 7125-delnp-2009-Form-3-(09-12-2015).pdf 09 Dec 2015
22 7125-delnp-2009-Form-2-(09-12-2015).pdf 09 Dec 2015
23 7125-delnp-2009-Form-1-(09-12-2015).pdf 09 Dec 2015
24 7125-delnp-2009-Drawings-(09-12-2015).pdf 09 Dec 2015
25 7125-delnp-2009-Correspondence Others-(09-12-2015).pdf 09 Dec 2015
26 7125-delnp-2009-Claims-(09-12-2015).pdf 09 Dec 2015
27 7125-delnp-2009-Assignment-(09-12-2015).pdf 09 Dec 2015
28 7125-delnp-2009-Abstract-(09-12-2015).pdf 09 Dec 2015
29 7125-DELNP-2009_EXAMREPORT.pdf 30 Jun 2016
30 Other Patent Document [10-03-2017(online)].pdf 10 Mar 2017
31 Form 3 [10-03-2017(online)].pdf 10 Mar 2017
32 282917-7125-delnp-2009.pdf 11 Aug 2018
33 7125-DELNP-2009-FORM 4 [19-09-2022(online)].pdf 19 Sep 2022
34 7125-DELNP-2009-FORM 4 [04-10-2023(online)].pdf 04 Oct 2023
35 7125-DELNP-2009-FORM 4 [01-10-2024(online)].pdf 01 Oct 2024

ERegister / renewals

Ceased
3rd Renewed 28 Jul 2017 Period 04 Apr 2010 – 04 Apr 2011 · CBR 24496 · Certificate 30488 ₹4,000
4th Renewed 28 Jul 2017 Period 04 Apr 2011 – 04 Apr 2012 · CBR 24496 · Certificate 30489 ₹4,000
5th Renewed 28 Jul 2017 Period 04 Apr 2012 – 04 Apr 2013 · CBR 24496 · Certificate 30490 ₹4,000
6th Renewed 28 Jul 2017 Period 04 Apr 2013 – 04 Apr 2014 · CBR 24496 · Certificate 30491 ₹4,000
7th Renewed 28 Jul 2017 Period 04 Apr 2014 – 04 Apr 2015 · CBR 24496 · Certificate 30492 ₹12,000
8th Renewed 28 Jul 2017 Period 04 Apr 2015 – 04 Apr 2016 · CBR 24496 · Certificate 30493 ₹12,000
9th Renewed 28 Jul 2017 Period 04 Apr 2016 – 04 Apr 2017 · CBR 24496 · Certificate 30494 ₹12,000
10th Renewed 28 Jul 2017 Period 04 Apr 2017 – 04 Apr 2018 · CBR 24496 · Certificate 30495 ₹12,000
11th Renewed 23 Mar 2018 Period 04 Apr 2018 – 04 Apr 2019 · CBR 7740 · Certificate 13148 ₹24,000
12th Renewed 31 Jan 2019 Period 04 Apr 2019 – 04 Apr 2020 · CBR 3314 · Certificate 4518 ₹24,000
13th Renewed 18 Sep 2020 Period 04 Apr 2020 – 04 Apr 2021 · CBR 31014 · Certificate 56337 ₹24,000
14th Renewed 03 Apr 2021 Period 04 Apr 2021 – 04 Apr 2022 · CBR 11826 · Certificate 22461 ₹24,000
15th Renewed 19 Sep 2022 Period 04 Apr 2022 – 04 Apr 2023 · CBR 35886 · Certificate 67403 ₹24,000
16th Renewed 04 Oct 2023 Period 04 Apr 2023 – 04 Apr 2024 · CBR 45560 · Certificate 100929 ₹40,000
17th Renewed 01 Oct 2024 Period 04 Apr 2024 – 04 Apr 2025 · CBR 60469 · Certificate 192605 ₹40,000